Enabling Collagen Quantification on HE-stained Slides Through Stain Deconvolution and Restained HE-HES
Authors:
Guillaume Balezo,
Christof A. Bertram,
Cyprien Tilmant,
Stéphanie Petit,
Saima Ben Hadj,
Rutger H. J. Fick
Abstract:
In histology, the presence of collagen in the extra-cellular matrix has both diagnostic and prognostic value for cancer malignancy, and can be highlighted by adding Saffron (S) to a routine Hematoxylin and Eosin (HE) staining. However, Saffron is not usually added because of the additional cost and because pathologists are accustomed to HE, with the exception of France-based laboratories. In this…
▽ More
In histology, the presence of collagen in the extra-cellular matrix has both diagnostic and prognostic value for cancer malignancy, and can be highlighted by adding Saffron (S) to a routine Hematoxylin and Eosin (HE) staining. However, Saffron is not usually added because of the additional cost and because pathologists are accustomed to HE, with the exception of France-based laboratories. In this paper, we show that it is possible to quantify the collagen content from the HE image alone and to digitally create an HES image. To do so, we trained a UNet to predict the Saffron densities from HE images. We created a dataset of registered, restained HE-HES slides and we extracted the Saffron concentrations as ground truth using stain deconvolution on the HES images. Our model reached a Mean Absolute Error of 0.0668 $\pm$ 0.0002 (Saffron values between 0 and 1) on a 3-fold testing set. We hope our approach can aid in improving the clinical workflow while reducing reagent costs for laboratories.
△ Less
Submitted 17 November, 2022;
originally announced November 2022.
Interpretable HER2 scoring by evaluating clinical Guidelines through a weakly supervised, constrained Deep Learning Approach
Authors:
Manh Dan Pham,
Cyprien Tilmant,
Stéphanie Petit,
Isabelle Salmon,
Saima Ben Hadj,
Rutger H. J. Fick
Abstract:
The evaluation of the Human Epidermal growth factor Receptor-2 (HER2) expression is an important prognostic biomarker for breast cancer treatment selection. However, HER2 scoring has notoriously high interobserver variability due to stain variations between centers and the need to estimate visually the staining intensity in specific percentages of tumor area. In this paper, focusing on the interpr…
▽ More
The evaluation of the Human Epidermal growth factor Receptor-2 (HER2) expression is an important prognostic biomarker for breast cancer treatment selection. However, HER2 scoring has notoriously high interobserver variability due to stain variations between centers and the need to estimate visually the staining intensity in specific percentages of tumor area. In this paper, focusing on the interpretability of HER2 scoring by a pathologist, we propose a semi-automatic, two-stage deep learning approach that directly evaluates the clinical HER2 guidelines defined by the American Society of Clinical Oncology/ College of American Pathologists (ASCO/CAP). In the first stage, we segment the invasive tumor over the user-indicated Region of Interest (ROI). Then, in the second stage, we classify the tumor tissue into four HER2 classes. For the classification stage, we use weakly supervised, constrained optimization to find a model that classifies cancerous patches such that the tumor surface percentage meets the guidelines specification of each HER2 class. We end the second stage by freezing the model and refining its output logits in a supervised way to all slide labels in the training set. To ensure the quality of our dataset's labels, we conducted a multi-pathologist HER2 scoring consensus. For the assessment of doubtful cases where no consensus was found, our model can help by interpreting its HER2 class percentages output. We achieve a performance of 0.78 in F1-score on the test set while kee** our model interpretable for the pathologist, hopefully contributing to interpretable AI models in digital pathology.
△ Less
Submitted 17 November, 2022;
originally announced November 2022.
